Zhang, Y., Zeng, L., Deng, J., Chen, X., Wang, J., Ruan, Z., Huang, Z., Tian, L., Zhao, C., Yang, N., Xiang, H. (2026). SHR-1701 combined with fuzuloparib and chemotherapy as first-line therapy for advanced lung squamous cell carcinoma: Efficacy and safety results from a phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8569